久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

Serving in the name of progress

By Zhong Nan | China Daily | Updated: 2017-09-08 07:29
Share
Share - WeChat

Joaquin Duato, executive vice-president and worldwide chairman of pharmaceuticals at Johnson & Johnson. [Photo provided to China Daily]

A senior executive at Johnson & Johnson talks about the group's strategy in China and the rest of the world

Joaquin Duato had dreams of playing tennis for Spain as a child.

At 55, he is now the executive vice-president and worldwide chairman of pharmaceuticals at blue chip brand Johnson& Johnson.

"I'm an avid tennis player and as a child I used to dream of one day representing Spain," he said during a visit to Beijing.

Instead he has represented the global healthcare giant for the past 28 years and helped shape the multinational's strategy in China and across the world.

"The healthcare and pharmaceutical industries have developed notably in China during the past three decades," Duato said. "Pharmaceutical companies are getting medicines to patients faster than they were before."

Moves by the China Food and Drug Administration to streamline the approval of new medicines have opened up the industry along with updating the National Reimbursement Drug List.

Last month, the Johnson & Johnson subsidiary, Xi'an Janssen Pharmaceutical Ltd, was granted approval from the CFDA for its Imbruvica capsules, which are used to treat adult patients with chronic lymphocytic leukemia and mantle cell lymphoma.

"These factors have improved the situation in China for innovation-based pharmaceutical companies," Duato added.

With more than 125,000 staff in nearly 60 countries and regions, Johnson & Johnson sells its products, such as consumer and healthcare, pharmaceuticals and medical devices, in about 200 nations and regions.

Naturally, China has become "vitally" important to the United States-based group.

In an interview with China Daily, Duato talked about the company's vision, its strategy in China, and his love of tennis and giant pandas.

What are Johnson & Johnson's plans in China during the next five years?

China is vitally important to us globally and we remain committed to investing in China, and making a significant contribution to the country's economic growth.

Since establishing operations here in 1985, we have expanded our presence significantly and today employ more than 2,500 people in our Beijing headquarters, our state-of-the-art manufacturing site in Xi'an, and our research and development operations. These include the groundbreaking R&D center in Shanghai and the Johnson & Johnson Innovation Center.

Following an investment of $290 million, our new supply chain hub for innovation in Asia is scheduled to open in Xi'an (in Shaanxi province) in 2019. The objective is to serve the rapidly expanding needs of China and other markets in the region. The plant is expected to set a new standard in pharmaceutical manufacturing here.

At full capacity, the plant is expected to produce 400 million tablets, capsules, creams, suppositories and powders a year.

What are your priorities in the country?

Globally, and in China, our strategy is to focus on discovering and developing transformational medical innovations for patients in six high priority disease areas, which address major unmet (unfulfilled) treatment needs.

These include oncology, immunology, neuroscience, infectious diseases, cardiovascular and pulmonary hypertension.

We will (also) continue to support China's aspiration to become a leading global pharmaceutical innovator through forward-looking investments. This will enable the discovery of game-changing therapies which address unmet medical needs.

What business opportunities will emerge through the Belt and Road Initiative?

Xi'an Janssen was, and will continue to be, a forerunner in establishing joint ventures with local partners in China. We established our operations in Shaanxi province in 1985, a critical area of the Belt and Road Initiative.

We also attribute these joint-venture partnerships and our continued investment in Xi'an as critical factors to our success in China. We will continue this model (in the future).

What is your biggest achievement here?

I am proud of guiding the business toward a greater focus on transformational medical innovations for patients.

Zytiga, a new kind of treatment for men with (a type of) prostate cancer, is a great example of cutting-edge science and true medical innovation that significantly prolongs lives.

How will you compete with competitors across the world and in China?

In 2011, we made the decision to focus our business on identifying and bringing transformational medical innovation. We are an innovation-based company which globally spends 50 percent more in research and development than in sales and marketing.

With a growing core business of medicines and a strong lineup of innovative products expected to launch or file during the next five years, we are leading the industry in advancing the health of patients around the world.

With our proven global commercial capabilities, we are well-positioned to continue delivering strong, long-term, sustainable growth.

How does digital technology affect your business?

Digital technology is important in discovery and development because we use information technology to screen targets and to model our clinical trial designs.

It is critical in manufacturing as we use machine learning and artificial intelligence, or AI, to identify areas in which we can eliminate waste and establish better quality control measures.

We now have access to vast amounts of data about how our medicines are used by physicians and patients once they are on the market. So this helps us better understand the risk-benefit ratio.

What makes an effective leader of a major multinational company?

I am proud to have worked at Johnson & Johnson for more than 28 years. I have had a varied career in different sectors of the healthcare industry, and in different countries and regions around the world. This has helped me continue to evolve and adapt my leadership style.

For the first half of my career, I was based in Europe and I was successful by using a direct, straight forward leadership style. But after moving to the United States I had to re-evaluate my style and learn to navigate cultural differences.

I would say my key leadership approach is adaptability-being able to draw upon what best suits the situation and the team I am leading.

How has your style changed over time?

Different business challenges need different leadership styles. When I became the head of our North American operation, I had to work quickly and alone to guide the business through a challenging turnaround.

But once it had stabilized, I had to open up to a more inclusive and consultative leadership style as we developed a long-term strategy for growth.

How do you handle setbacks?

I view setbacks as opportunities to grow, both as an individual and as a business. The challenges and hardships our group faced during the 2007 recession can almost be seen as a necessary step in achieving the remarkable success we have today.

The setbacks we faced forced us to make our organization a leaner and more focused operation. Our extremely successful model of embracing innovation was born.

So now, whenever I am faced with a setback, I always look for an opportunity that might arise.

What are your hobbies?

My role involves a lot of travel, so whenever I am at home my first priority is spending time with my family. I love being with my wife, son and daughter.

This summer, I have spent a number of days traveling with my family to visit potential colleges that my daughter might attend next year.

I am also an avid tennis player and as a child I used to dream of one day representing Spain.

How do you spend your free time in China?

Usually, I am focused on meetings with customers and government officials. But I understand that through our collaboration with Shaanxi Rare Wild Animals Rescue and Research Center, which aims to further protect the giant panda in China, we had the honor of naming a baby panda "Johnson& Johnson". If I have free time, I am hoping to visit him.

CV

Age: 55

Nationality: Spanish and American

Career:

2017 onwards: Chairman of the Board, PhRMA

2011 onwards: Worldwide Chairman, Pharmaceuticals, Johnson& Johnson

2009-11: Company Group Chairman, Americas, The Janssen Pharmaceutical Companies of Johnson& Johnson

2007-09: Company Group Chairman, Diagnostics, Johnson & Johnson

2005-07: President, Ortho Biotech Products LP, Johnson& Johnson

Education: Undergraduate degree in Economics and Business

MBA from ESADE, Barcelona

Masters of International Management from Thunderbird, Phoenix, US.

Family: Married with a son and a daughter

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    久久视频这里有精品| 天天做天天干天天操| 中文字幕在线视频一区二区三区| 久久久天堂国产精品| 日本在线视频www| 免费cad大片在线观看| 日本激情视频在线播放| 97免费视频观看| 超碰中文字幕在线观看| 国产欧美高清在线| 男女日批视频在线观看| 成年人免费观看的视频| 亚洲 中文字幕 日韩 无码| 国产免费黄色一级片| 中文字幕一区二区三区四区五区人| chinese少妇国语对白| 欧美黑人在线观看| 91亚洲一区二区| www.99在线| 免费无码国产v片在线观看| 黄色一级片国产| 中国 免费 av| 超碰在线免费av| 午夜免费福利在线| 免费在线观看的毛片| 国产素人在线观看| 糖心vlog在线免费观看| 国产永久免费网站| 婷婷免费在线观看| 青青草av网站| 免费黄色一级网站| 久久久久久久久久福利| 99精品人妻少妇一区二区| 99热亚洲精品| 91成人在线观看喷潮教学| 国产精品久久久久久久乖乖| 欧美 亚洲 视频| 天天想你在线观看完整版电影免费| 免费黄频在线观看| 中文字幕网av| 中文字幕 日韩 欧美| 亚洲视频第二页| 99热一区二区| www.午夜av| 在线成人免费av| 黄色影视在线观看| 无码人妻精品一区二区蜜桃百度| 女同性恋一区二区| 99er在线视频| av女优在线播放| 久久99中文字幕| 久久久999免费视频| 极品美女扒开粉嫩小泬| 俄罗斯av网站| www.日本xxxx| 黄色小视频免费网站| 999热精品视频| ijzzijzzij亚洲大全| 免费成人深夜夜行网站视频| 日韩video| 日本xxxxxxxxxx75| 人妻内射一区二区在线视频 | 怡红院亚洲色图| 精品综合久久久久| 大地资源第二页在线观看高清版| 91精品国产毛片武则天| 亚洲熟妇无码av在线播放| 极品美女扒开粉嫩小泬| 日韩福利视频在线| 国产又粗又长又爽又黄的视频| 99精品一区二区三区的区别| 污污污污污污www网站免费| 精品久久一二三| 在线观看的毛片| 一本二本三本亚洲码| xxxx18hd亚洲hd捆绑| 日韩视频免费在线播放| 久久久福利影院| 欧美a级免费视频| 欧美综合在线观看视频| 九九热精品国产| 国产精品久久久久9999爆乳| 成人3d动漫一区二区三区| xxx中文字幕| 欧美这里只有精品| 亚洲少妇第一页| 一区二区三区四区免费观看| 99爱视频在线| 亚洲五月激情网| 久久综合色视频| 黄色小视频免费网站| 精品久久久久久无码中文野结衣| av在线无限看| 欧美久久久久久久久久久久久久| 国产成人无码av在线播放dvd| 国产农村妇女精品久久| 日本日本19xxxⅹhd乱影响| 中文字幕 日韩 欧美| 全黄性性激高免费视频| 中文字幕22页| 欧美综合在线播放| 亚洲av无日韩毛片久久| 国产网站免费在线观看| 免费看啪啪网站| 国产淫片av片久久久久久| 佐佐木明希av| 国产一伦一伦一伦| 国产免费黄色一级片| 99中文字幕在线| 欧美性大战久久久久xxx| 国产欧美自拍视频| 久久久久久久片| 97超碰国产精品| 天堂中文av在线| 国产成人黄色片| 999久久欧美人妻一区二区| 婷婷六月天在线| 国产精品专区在线| 成人手机在线播放| 爱爱爱爱免费视频| 日本中文字幕片| 国产精品久久国产| 老司机av福利| 日本a√在线观看| 玩弄中年熟妇正在播放| 国产日产欧美一区二区| 在线看免费毛片| 91热这里只有精品| 无码精品a∨在线观看中文| 国产黄色激情视频| 色乱码一区二区三区熟女| 性欧美1819| 五月婷婷狠狠操| 大陆极品少妇内射aaaaa| 国产毛片久久久久久国产毛片| 三级av免费看| 日本中文字幕精品—区二区| 免费在线观看毛片网站| 日本毛片在线免费观看| 2019日韩中文字幕mv| 蜜臀av性久久久久蜜臀av| 先锋影音男人资源| 色偷偷中文字幕| 超碰91在线播放| 欧美在线a视频| 91精产国品一二三产区别沈先生| 日本新janpanese乱熟| 男人天堂999| 成人观看免费完整观看| 91猫先生在线| 色综合久久久久无码专区| 99热亚洲精品| 国产综合中文字幕| 成 年 人 黄 色 大 片大 全| 日本一本中文字幕| 日韩欧美不卡在线| 日日摸日日碰夜夜爽无码| 黄色成人在线看| 日韩在线综合网| 中国丰满人妻videoshd| 成人久久久久久久久| 蜜臀av午夜一区二区三区| 亚洲五月天综合| 色婷婷.com| 污视频在线观看免费网站| www.久久com| 日本免费成人网| 我的公把我弄高潮了视频| 欧美日韩亚洲一| 国产日韩成人内射视频| 九九热在线免费| 韩国一区二区在线播放| 麻豆md0077饥渴少妇| 国产av熟女一区二区三区| 人妻av中文系列| 黄色一级大片在线观看| 91制片厂毛片| 日本特级黄色大片| 日韩黄色片在线| 男女av免费观看| 五月婷婷六月合| 激情五月五月婷婷| 少妇人妻在线视频| 另类小说第一页| 熟女视频一区二区三区| 欧美狂野激情性xxxx在线观| 男人亚洲天堂网| 亚洲欧美日本一区二区三区| 欧美一级特黄aaaaaa在线看片| 加勒比成人在线| 日韩欧美在线免费观看视频| 亚洲综合20p| 日韩中字在线观看| 九色porny自拍| 国产卡一卡二在线| 欧美大片在线播放| 欧美女同在线观看| 大荫蒂性生交片| 国产又粗又长又大的视频| av电影一区二区三区|